Presynaptic serotonin (5-hydroxytryptamine, 5-HT) transporters (SERTs) constitute the primary mechanism for inactivation of 5HT and are high-affinity targets for important addictive and therapeutic drugs including MDMA, fenfluramine, cocaine, tricyclics and SSRIs. In our previous funding period, we and collaborators cloned human, mouse and Drosophila melanogaster SERT cDNAs, mapped the human gene to chromosome 17q11.2, mapped protein contact sites for SERT antagonists including tricyclics, mazindol and citalopram, identified kinase-linked pathways supporting acute hSERT regulation, replicated SERT regulation under voltage-clamp and demonstrated polarized surface expression of SERT proteins. Our goal in this renewal application is to more completely understand how SERTs are organized at the plasma membrane and how transport is modulated by extracellular signals and intracellular signaling pathways. Our published and preliminary studies reveal kinase and phosphatase-dependent modulation of SERT transport capacity, SERT-regulatory trafficking pathways, 5HT-modulated phosphorylation states, and SERT-associated proteins. In this renewal, we evaluate the structural requirements for SERT membrane expression, phosphorylation and sequestration, evaluate whether SERT phosphorylation is required for acute transporter regulation, and establish the structural and functional basis of interactions with SERT-associated proteins. Using patch clamp techniques, we will explore the possibility that SERTs exist in the plasma membrane associated with regulatory enzymes that can modify transport activity prior to, or as a requirement for, sequestration. These studies will also shed light on how SERT functional expression is controlled by presynaptic hetero- and autoreceptors and transport-modulatory ligands, including the amphetamines and 5HT itself. Our studies offer opportunities for new insights into mechanisms of drug action and may uncover strategies for the design of novel therapeutics that manipulate amine transporter reulation rather than interfering with 5HT recognition. SERT homologies with other gene family members, including NETs and DATs, suggests that advances made with SERTs may have heuristic and practical benefits for the study of other neurotransmitter transporters linked to mental illness and drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA007390-11
Application #
6175607
Study Section
Special Emphasis Panel (ZRG1-MDCN-4 (01))
Program Officer
Pilotte, Nancy S
Project Start
1994-08-01
Project End
2004-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
11
Fiscal Year
2000
Total Cost
$398,497
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Mergy, Marc A; Gowrishankar, Raajaram; Davis, Gwynne L et al. (2014) Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochem Int 73:56-70
Ye, R; Carneiro, A M D; Airey, D et al. (2014) Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice. Genes Brain Behav 13:247-60
Moritz, Amy E; Foster, James D; Gorentla, Balachandra K et al. (2013) Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. J Biol Chem 288:20-32
Veenstra-VanderWeele, Jeremy; Muller, Christopher L; Iwamoto, Hideki et al. (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 109:5469-74
Kovtun, Oleg; Tomlinson, Ian D; Sakrikar, Dhananjay S et al. (2011) Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. ACS Chem Neurosci 2:370-8
Zhu, Chong-Bin; Lindler, Kathryn M; Campbell, Nicholas G et al. (2011) Colocalization and regulated physical association of presynaptic serotonin transporters with A? adenosine receptors. Mol Pharmacol 80:458-65
Ye, R; Blakely, R D (2011) Natural and engineered coding variation in antidepressant-sensitive serotonin transporters. Neuroscience 197:28-36
Thompson, Brent J; Jessen, Tammy; Henry, L K et al. (2011) Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proc Natl Acad Sci U S A 108:3785-90
Field, Julie R; Henry, L Keith; Blakely, Randy D (2010) Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. J Biol Chem 285:11270-80
Zhu, Chong-Bin; Lindler, Kathryn M; Owens, Anthony W et al. (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35:2510-20

Showing the most recent 10 out of 73 publications